TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 80 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,756 | -33.6% | 7,600 | -36.1% | 0.01% | -30.0% |
| Q1 2024 | $77,992 | +68.1% | 11,889 | +66.3% | 0.01% | +11.1% |
| Q4 2023 | $46,384 | +491.1% | 7,147 | +358.1% | 0.01% | +350.0% |
| Q3 2023 | $7,847 | +20.7% | 1,560 | +110.0% | 0.00% | 0.0% |
| Q2 2023 | $6,501 | -18.2% | 743 | +10.7% | 0.00% | -33.3% |
| Q1 2023 | $7,945 | +103.8% | 671 | +75.2% | 0.00% | +50.0% |
| Q4 2022 | $3,899 | +95.0% | 383 | +8.5% | 0.00% | +100.0% |
| Q3 2022 | $2,000 | – | 353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2,121,000 | 0.65% |
| Vivo Capital, LLC | 2,675,133 | $7,945,000 | 0.55% |
| Samsara BioCapital, LLC | 289,068 | $859,000 | 0.22% |
| Orbimed Advisors | 3,791,204 | $11,260,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $6,967,000 | 0.16% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,238,800 | $3,679,000 | 0.11% |
| Antara Capital LP | 1,074,834 | $3,192,000 | 0.10% |
| COWEN AND COMPANY, LLC | 85,000 | $252,000 | 0.02% |
| Marquette Asset Management, LLC | 21,802 | $65,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 85,851 | $255,000 | 0.01% |